Lithium pharmacokinetics in Chinese manic-depressive patients

Journal of Clinical Psychopharmacology

Volumn 17, Issue 3, 1997, Pages 179-184

  Wing, Yun Kwok ^a   Chan, Eli ^c   Chan, Kelvin ^d   Lee, Sing ^a   Shek, Chi Chung ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CHLORPROMAZINE; DOSULEPIN; HALOPERIDOL; IMIPRAMINE; LITHICARB; LITHIUM CARBONATE; NIFEDIPINE; TEMAZEPAM; THIORIDAZINE; TRIHEXYPHENIDYL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARTMENT MODEL; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG URINE LEVEL; FEMALE; HUMAN; LITHIUM BLOOD LEVEL; MAINTENANCE THERAPY; MALE; MANIC DEPRESSIVE PSYCHOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL AVAILABILITY; BIPOLAR DISORDER; CHINA; FEMALE; HALF-LIFE; HONG KONG; HUMANS; LITHIUM CARBONATE; MALE; METABOLIC CLEARANCE RATE;

EID: 0030938163     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199706000-00007     Document Type: Article

References (24)

1. Schou M. Lithium in psychiatric therapy and prophylaxis. J Psychiatr Res 1968;6:67-95.
2. Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, Johnson WE. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychiatry 1984;41:1096-104.
3. Stokes PE, Kocsis JH, Arcuni OJ. Relationship of lithium chloride dose to treatment response in acute mania. Arch Gen Psychiatry 1976;33:1080-4.
4. Persson G. Lithium side effects in relation to dose and to levels and gradients of lithium in plasma. Acta Psychiatr Scand 1977;55: 208-13.
5. Schweyen DH, Sporka MC, Burnakis TG. Evaluation of serum lithium concentration determinations. Am J Hosp Pharm 1991;48: 1536-7.
6. Mason RW, McQueen EG, Keary PJ, James NM. Pharmacokinetics of lithium: elimination half-time, renal clearance and apparent volume of distribution in Schizophrenia. Clin Pharmacokinet 1978;3:241-6.
7. Johnson GFS, Hunt GE, George BS. Pharmacokinetics of standard (Lithicarb) and sustained-release (Priadel) lithium carbonate preparations in patients. Aust N Z J Psychiatry 1982;16:64-8.
8. Gaillot J, Steimer J-LJ, Mallet AJ, Thebault JJ, Bieder A. A priori lithium dosage regimen using population characteristics of pharmacokinetic parameters. J Pharmacokinet Biopharm 1979;7: 579-628.
9. Shelley RK, Silverstone T. Single dose pharmacokinetics of 5 formulations of lithium: a controlled comparison in healthy subjects. Int J Clin Psychopharmacol 1986;1:324-31.
10. Luisier PA, Schulz P, Dick P. The pharmacokinetics of lithium in normal humans: expected and unexpected observations in view of basic kinetic principles. Pharmacopsychiatry 1987;20:232-4.
11. Hunter R. Steady-state pharmacokinetics of lithium carbonate in healthy subjects. Br J Clin Pharmacol 1988;25:375-80.
12. Jiang ZN, Wang Z, Lei MH. Screening and evaluation on predictive factors in lithium carbonate maintenance treatment for manic-depressive disorders. Chung Hua Shen Ching Ching Shen Ko Tsa Chih 1990;23:324-8.
13. Lee S. The first lithium clinic in Hong Kong: a Chinese profile. Aust N Z J Psychiatry 1992;26:450-3.
14. Coppen A, Abou-Saleh MT. Lithium therapy: from clinical trials to practical management. Acta Psychiatr Scand 1988;78:754-62.
15. Anderson DN. A comparison of in-patient and out-patient prescribing. Br J Psychiatry 1989;154:644-9.
16. Rowland M, Tozer TN. Clinical pharmacokinetics, concepts and applications. 2nd ed. Philadelphia: Lea & Febiger, 1989.
17. Hallynck TH, Soep HH, Thomis JA. Clearance be normalised to body surface area or lean body mass? Br J Clin Pharmacol 1981;11:523-6.
18. Lin KM, Poland RE, Nakasaki MSW, eds. Psychopharmacology and psychobiology of ethnicity. Washington, DC: American Psychiatric Press, 1993.
19. Chang WH, Chen TY, Lee CF, Hu WH, Yeh EK. Low plasma reduced haloperidol/haloperidol ratios in Chinese patients. Biol Psychiatry 1987;22:1406-8.
20. Shelley RK. Are there ethnic differences in lithium pharmacokinetics and side-effects? Int Clin Psychopharmacol 1987;2:337-42.
21. Reiss RA, Haas CE, Karki SD, Gumbiner B, Welle SL, Carson SW. Lithium pharmacokinetics in the obese. Clin Pharmacol Ther 1994;55:392-8.
22. Jermain DM, Crismon ML, Martin ES. Population pharmacokinetics of lithium. Clin Pharm 1991;10:376-81.
23. Lee S. The prevalence and nature of lithium noncompliance among Chinese psychiatric patients in Hong Kong. J Nerv Ment Dis 1993;181:618-25.
24. Yang YY. Prophylactic efficacy of lithium and its effective plasma levels in Chinese bipolar patients. Acta Psychiatr Scand 1985; 71:171-5.